PMV Pharmaceuticals, Inc. (PMVP) Stock: Dividends & Earnings

Company Overview:

Market Cap: $0

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $1.02 - $1.88

6 Year PMVP Performance Metrics:

Total Return (with DRIP): -95.5% (-40.47% CAGR)

Total Return (no DRIP): -95.5% (-40.47% CAGR)

Share Price: -95.5% (-40.47% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $445

Total Return $ (with DRIP): -$9,555

PMVP Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

PMVP Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for PMVP

Based on past 6-year performance, here are PMVP growth metrics:

Share price CAGR of -40.47%
Dividend CAGR of +0%

Using PMVP CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	PMVP (DRIP)	PMVP - No DRIP
Current Price	$1.67	$1.67
Start Shares	5,988.02	5,988.02
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	5,988.02	5,988.02
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$0.01	$1.67
Total Dividends	$0	$0
Final Value	$56	$10,000

Estimated Future Value + Dividends - PMVP

NOTE: Above numbers are our estimate based on PMVP's Dividend and Price CAGR over past 6 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

PMV Pharmaceuticals, Inc. (PMVP) had its IPO on , and is traded on NASDAQ stock exchange.

PMV Pharmaceuticals, Inc. is a precision oncology biotechnology company focused on discovering and developing small-molecule therapies that target p53 mutations in cancer. The company’s lead program, rezatapopt, is designed as a selective p53 reactivator for tumors carrying the Y220C mutation, with a tumor-agnostic approach that aims to address cancers across multiple tissue types. PMV Pharmaceuticals concentrates on translational research and clinical development for advanced solid tumors, combining drug discovery with mutation-specific biology to create targeted treatment options. Based in Princeton, New Jersey, the company operates within the broader cancer therapeutics market and is recognized for its work in mutant p53 biology and small-molecule precision medicine.

PMVP website: https://www.pmvpharma.com